| |
The EPRC operates in liaison with other bodies, local and international, according to the Sponsor’s requirements:
|
 |
Central laboratories for safety screens
|
|
GLP bioanalytical laboratories
|
|
CROs for data management and monitoring on behalf of the Sponsor |
|
Other medical institutes for recruitment of additional patients |
................................................................................................................................................................................................................. |
| |
Additional Services |
| |
The EPRC also: |
|
Conducts bioequivalence, Phase I and Phase IIa trials as a subcontractor for CROs |
|
Liaises between potential clients and CROs in matters concerning monitoring, data management, etc. |
|
Participates in large scale studies in which the involvement of a dedicated clinical pharmacology unit is required (e.g., a PK drug-interaction sub-study) |
